Clinical Trials in Denver

Showing 9821-9840 of 13,773 trials

The Effects of A Proprietary Spearmint Extract on Cognitive Performance

NCT02518165

This study was designed to evaluate the chronic effects of a proprietary spearmint extract over 90 days of supplementation on aspects of cognitive performance (cognitive function and active reaction time), subjective mood, and sleep quality in healthy men and women.

MoodCognitive PerformanceSleep

Kemin Foods LC142 participantsStarted Apr 2015

Denver, Colorado, United States

TERMINATEDNA< 1 mile

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

NCT03020121

The purpose of the study is to compare the results of the Becton Dickinson (BD) Human Papilloma Virus (HPV) Assay on the Viper LT instrument from Liquid-based cytology media diluted in HPV diluent to adjudicated histology results from biopsy.

Uterine Cervical Neoplasm

Becton, Dickinson and Company28 participantsStarted Nov 2016

Denver, Colorado, United States • Denver, Colorado, United States • West Palm Beach, Florida, United States +9 more locations

COMPLETEDPhase 3< 1 mile

Lesinurad and Febuxostat Combination Extension Study in Gout

NCT01808144

This study will assess the serum uric acid lowering effects and safety of lesinurad in combination with febuxostat over a long-term timeframe.

Gout

Ardea Biosciences, Inc.196 participantsStarted Mar 2013

Birmingham, Alabama, United States • Tempe, Arizona, United States • Glendale, California, United States +69 more locations

The Effects of A Proprietary Spearmint Extract on Cognitive Performance

Validation of BD Onclarity™ HPV Assay With PreservCyt® -ASCUS Samples

Lesinurad and Febuxostat Combination Extension Study in Gout

Find Trials by Condition in Denver

NOLAN: Naproxen or Loratadine and Neulasta

Evaluate the Efficacy and Safety of Arhalofenate for Preventing Flares and Reducing Serum Uric Acid in Gout Patients

Comparative Effectiveness of Family Problem-Solving Therapy (F-PST) for Adolescent TBI

Asthma Exacerbation Study

Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma

Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate

Improving Well-Being After TBI Through Structured Volunteer Activity

Improving the Selection of Patients With Glioblastoma Multiforme for Treatment With Epidermal Growth Factor Receptor Inhibitor Therapies

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

A 24-week Evaluation of GSK573719/Vilanterol (125/25mcg) and Components in COPD

Ciprofloxacin Dry Powder for Inhalation in Non-cystic Fibrosis Bronchiectasis (Non-CF BE)

Study of INCB039110 in Combination With Docetaxel in Subjects With Non-Small Cell Lung Cancer

The Purpose of This Study is to Evaluate the Spirometric Effect (Trough FEV1) of Umeclidinium/Vilanterol 62.5/25 mcg Once Daily Compared With Tiotriopium 18 mcg Once Daily Over a 24-week Treatment Period in Subjects With COPD

Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal Cancer

Effectiveness of Aurix Therapy in Pressure Ulcers

Study Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Inhalation Powder (FF/VI) Compared With Vilanterol Inhalation Powder (VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Systems of Support Study for Childhood Depression